New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.

The women's telehealth company Midi said Tuesday it's launching a longevity care program that will be covered by private insurers nationwide. Why it matters: Longevity care is booming, but it mostly ...

This week, Vail Health launches its new Healthspan program, designed to take a natural, science-based approach to improving quality of life and longevity. “Healthspan, at its core, is a lifestyle ...

Positioning The University of Texas at San Antonio as a national anchor for aging and longevity science, its Sam and Ann ...

Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics market HYFT®-driven discovery supports ...

First publicly listed company to actively investigate psilocybin’s potential impact on longevity Working closely with an academic neuroscience faculty, Psyence BioMed is developing an accelerated ...

TOKYO, Japan, January 21, 2014 — Renesas Electronics Corporation (TSE: 6723), a premier provider of advanced semiconductor solutions, today introduced a product longevity program (PLP) to communicate ...